Spectrum Library

What’s new in neuromyelitis optica? A short review for the clinical neurologist.

Publication Date March 2017

Pathogenic Implications of cerebrospinal barrier pathology in neuromyelitis optica.

Publication Date February 2017

Effects of neuromyelitis optica–IgG at the blood–brain barrier in vitro

Publication Date December 2016

MOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsy

Publication Date January 2017

Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica

Publication Date December 2016

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4

Publication Date November 2016

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3:

Publication Date November 2016

Immunology of neuromyelitis optica during pregnancy.

Publication Date October 2016

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Publication Date September 2016

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.

Publication Date September 2016

Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India

Publication Date October 2016

Patient-reported outcome measure for neuromyelitis optica: pretesting of preliminary instrument and protocol for further development in accordance with international guidelines.

Publication Date October 2016

Previous
1
…
8
9
10
11
12
…
78
Next

Launch Dashboard